Segra leads the cannabis industry with its cutting-edge Cannabis nursery, Plant Tissue Culture, and DNA fingerprinting technologies. Their ground-breaking work in pathogen detection, Hop Latent Viroid testing, and exclusive partnerships, empowering growers worldwide with high-yielding, true-to-type plants.

Dr. John Brunstein, Scientific Advisory Board Member has assembled his research to take a closer look at Mitovirus in cannabis plants and it’s positive or negative impacts.

Dr. John Brunstein, our Chief Scientific Officer, has assembled a document outlining best practices for detecting, managing, and mitigating Hop Latent Viriod (HLVd).

The global cannabis industry has witnessed exponential growth over the past decade, with legalization and decriminalization efforts sweeping across various countries. At the heart of this burgeoning market lies the crucial role of cannabis nurseries, which serve as the foundation for quality cultivation and genetic diversity. Among these, Canadian cannabis nurseries have emerged as key players on the international stage.

Dr. Sma Zobayed, Chief Tissue Culture Officer at Segra International explores The Ins and Outs of Tissue Culture Production.

Cannabis plant variety & their genetic identification.  Where do cannabis names come from?  Discussed by Dr. John Brunstein, Chief Scientific Officer at Segra

Nanopore NGS Panel for Examination of Key Genes on Cannabinoid and Terpenoid Synthetic Pathways‍

‍How cannabis production will evolve in 2021 with the help of Plant Tissue Culture (PTC)

Dr. Sma Zobayed, Segra’s Chief Tissue Culture Officer, October 2020

Dr. John Brunstein, Segra’s Chief Scientific Officer, Cannabis and Tech Today (September 2019)

Dr. John Brunstein, Segra’s Chief Scientific Officer, Cannabis and Tech Today (October 2019)

Dr. John Brunstein, Segra’s Chief Scientific Officer, Cannabis and Tech Today (March 2020)

Dr. John Brunstein, Segra’s Chief Scientific Officer, at ICR 2020